Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Risperidone

"Risperidone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.


This graph shows the total number of publications written about "Risperidone" by people in Harvard Catalyst Profiles by year, and whether "Risperidone" was a major or minor topic of these publication.
Bar chart showing 237 publications over 25 distinct years, with a maximum of 20 publications in 2006
To see the data from this visualization as text, click here.
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.